The health AI "super app" wants to add more nutrition data to its platform with this buy, its second acquisition of the yar.

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

If you are looking to get a weight loss drug but lack insurance coverage, telehealth websites such as Ro, Hers and Mochi ...

Telehealth and wellness platform Hims & Hers on Monday offered a revenue outlook for the year ahead that topped Wall Street’s expectations, but shares fell hard in after-hours trading ...

Hims & Hers Health HIMS is well-positioned for growth as it addresses a vast unmet healthcare market, leveraging a total addressable market of $360M across specialties like mental health, weight ...

Platforms like Hims, launched in 2017, have quickly grown in popularity by providing convenient, discreet, and direct online access to treatment options. Hims reported nearly $900 million in revenue ...

To get there, Hims will need to be more than just another distributor of Wegovy. Rival telehealth platforms Ro and LifeMD have also made deals with Novo to sell the drug. Customers who have grown ...

With Hims & Hers stock currently trading at ~$52 per share, HIMS has undoubtedly been one of my biggest winners! Today, we shall analyze Hims & Hers' Q1 2025 report, business outlook, valuation ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Quantitative Momentum Investor model based on the ...